Evotec SE: LG Launches Groundbreaking Micro RGB evo TV at CES 2026
- LG Electronics launched the Micro RGB evo, its first flagship RGB television, showcasing advanced display technology at CES 2026.
- The Micro RGB evo features the α 11 AI Processor Gen 3 for enhanced image quality and color reproduction.
- LG received a CES 2026 Innovation Award for the Micro RGB evo, emphasizing its commitment to display technology innovation.
LG Electronics Unveils Innovative Micro RGB evo Television at CES 2026
LG Electronics makes a significant stride in display technology by introducing the LG Micro RGB evo, its first flagship RGB television, at CES 2026. This cutting-edge product marks a pivotal advancement from previous technologies, featuring the company's smallest individual RGB LEDs. The Micro RGB Technology not only enhances the visual experience but also reflects LG's 13 years of expertise in OLED technology. By skillfully controlling each RGB LED backlight, LG aims to set a new standard in the television market, attracting both tech enthusiasts and professionals who demand superior image quality.
The LG Micro RGB evo is powered by the advanced Dual AI Engine-based α (Alpha) 11 AI Processor Gen 3, which incorporates Dual Super Upscaling. This dual processing capability allows for simultaneous AI-driven enhancements, resulting in sharper images and more natural visuals. With an impressive color reproduction that achieves 100% coverage in BT.2020, DCI-P3, and Adobe RGB, the device is poised to cater to a variety of applications, including digital editing and HDR cinema. Certified by Intertek, this television not only meets but exceeds the expectations for next-generation display technologies, thus positioning LG as a leader in the competitive market of high-end televisions.
Moreover, the LG Micro RGB evo features the Micro Dimming Ultra capability, which manages over a thousand dimming zones. This feature ensures that users experience exceptional contrast and precise brightness and color control, revealing intricate details even under varying lighting conditions. Enhancing the user experience further, LG integrates its award-winning webOS platform, which includes personalized features like Voice ID and an AI Picture/Sound Wizard. The upgraded AI Concierge, AI Chatbot, and AI Search functionalities facilitate effortless content exploration, making the Micro RGB evo not only a marvel in picture quality but also a sophisticated solution for an enriched viewing experience.
In addition to the impressive technical specifications, LG’s commitment to innovation is evident through its receipt of a CES 2026 Innovation Award for the Micro RGB evo. This accolade underscores the company's dedication to pushing the boundaries of display technology and enhancing user engagement.
The introduction of the Micro RGB evo aligns with LG's strategy to integrate advanced technology with user-friendly features. As the demand for high-quality displays continues to grow, LG's latest offering positions the company well within the evolving landscape of television technology, setting a benchmark for competitors and catering to the needs of a diverse consumer base.
Related Cashu News

Bristol-Myers Squibb's Reclassification Enhances Growth Potential in Defensive Investment Strategy
Bristol-Myers Squibb Company (Ticker: BMY) undergoes a key reclassification across the Russell indexes, marking a transformative moment for the company. Moving to the Russell 1000 Defensive and Russel…

Vertex Pharmaceuticals' Casgevy Gains FDA Approval for Expanded Sickle Cell Disease Treatment Options
Vertex Pharmaceuticals (Ticker: VRTX) receives a significant boost in its ongoing battle against sickle cell disease with the recent FDA approval of an expanded label for its gene therapy product, Cas…

Gilead Sciences Gains FDA Approval for Trodelvy in First-Line Triple-Negative Breast Cancer Treatment
Gilead Sciences (Ticker: GILD) makes significant strides in oncology therapy with the recent approval of its drug Trodelvy for patients with unresectable or metastatic triple-negative breast cancer. T…

Merck Advances HIV Treatment and Faces Regulatory Scrutiny Amidst Market Success
Merck & Co. (Ticker: MRK) has recently made significant strides in the pharmaceutical landscape, particularly with its advancements in HIV treatment. The company's innovative drug, IDVYNSO, has receiv…

